CN102716315A - 一种补肾阳保健药酒及其制备方法 - Google Patents
一种补肾阳保健药酒及其制备方法 Download PDFInfo
- Publication number
- CN102716315A CN102716315A CN2012102247480A CN201210224748A CN102716315A CN 102716315 A CN102716315 A CN 102716315A CN 2012102247480 A CN2012102247480 A CN 2012102247480A CN 201210224748 A CN201210224748 A CN 201210224748A CN 102716315 A CN102716315 A CN 102716315A
- Authority
- CN
- China
- Prior art keywords
- weight portion
- kidney
- medicated wine
- yang
- chinese liquor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000003734 kidney Anatomy 0.000 title abstract description 38
- 230000036541 health Effects 0.000 title abstract description 25
- 238000002360 preparation method Methods 0.000 title abstract description 17
- 239000003814 drug Substances 0.000 claims abstract description 39
- 210000000582 semen Anatomy 0.000 claims abstract description 32
- 241000005787 Cistanche Species 0.000 claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 238000010992 reflux Methods 0.000 claims description 35
- 238000000034 method Methods 0.000 claims description 33
- 229940079593 drug Drugs 0.000 claims description 17
- 239000000706 filtrate Substances 0.000 claims description 15
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 14
- 238000000605 extraction Methods 0.000 claims description 11
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 10
- 238000005303 weighing Methods 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 8
- 238000002791 soaking Methods 0.000 claims description 8
- 230000001476 alcoholic effect Effects 0.000 claims description 6
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 5
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 5
- 235000021551 crystal sugar Nutrition 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 5
- 235000000346 sugar Nutrition 0.000 claims description 5
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 4
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 4
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 4
- 229930006000 Sucrose Natural products 0.000 claims description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 4
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 4
- 229940013618 stevioside Drugs 0.000 claims description 4
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 4
- 235000019202 steviosides Nutrition 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 55
- 230000001568 sexual effect Effects 0.000 abstract description 20
- 210000004185 liver Anatomy 0.000 abstract description 11
- 238000005728 strengthening Methods 0.000 abstract description 10
- 239000008280 blood Substances 0.000 abstract description 8
- 210000004369 blood Anatomy 0.000 abstract description 7
- 238000010792 warming Methods 0.000 abstract description 7
- 210000003205 muscle Anatomy 0.000 abstract description 6
- 208000031975 Yang Deficiency Diseases 0.000 abstract description 5
- 230000036039 immunity Effects 0.000 abstract description 4
- 230000032683 aging Effects 0.000 abstract description 3
- 210000000988 bone and bone Anatomy 0.000 abstract description 3
- 235000015096 spirit Nutrition 0.000 abstract 2
- 240000006766 Cornus mas Species 0.000 abstract 1
- 235000017784 Mespilus germanica Nutrition 0.000 abstract 1
- 244000182216 Mimusops elengi Species 0.000 abstract 1
- 235000000560 Mimusops elengi Nutrition 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 241000405911 Rehmannia glutinosa Species 0.000 abstract 1
- 235000007837 Vangueria infausta Nutrition 0.000 abstract 1
- 244000089698 Zanthoxylum simulans Species 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 description 29
- 241000699666 Mus <mouse, genus> Species 0.000 description 18
- 238000012360 testing method Methods 0.000 description 18
- 230000037396 body weight Effects 0.000 description 16
- 206010016256 fatigue Diseases 0.000 description 16
- 208000024891 symptom Diseases 0.000 description 16
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 15
- 239000000047 product Substances 0.000 description 15
- 201000001881 impotence Diseases 0.000 description 13
- 208000010228 Erectile Dysfunction Diseases 0.000 description 12
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 12
- 230000007812 deficiency Effects 0.000 description 11
- 201000010099 disease Diseases 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 230000013011 mating Effects 0.000 description 11
- 230000003203 everyday effect Effects 0.000 description 10
- 210000002784 stomach Anatomy 0.000 description 10
- 238000012856 packing Methods 0.000 description 9
- 206010021143 Hypoxia Diseases 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 210000000918 epididymis Anatomy 0.000 description 7
- 201000010063 epididymitis Diseases 0.000 description 7
- 210000004100 adrenal gland Anatomy 0.000 description 6
- 229960000890 hydrocortisone Drugs 0.000 description 6
- 230000007954 hypoxia Effects 0.000 description 6
- 208000033065 inborn errors of immunity Diseases 0.000 description 6
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 6
- 238000010998 test method Methods 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 210000002381 plasma Anatomy 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 230000004083 survival effect Effects 0.000 description 5
- 230000009182 swimming Effects 0.000 description 5
- 208000008035 Back Pain Diseases 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 238000012449 Kunming mouse Methods 0.000 description 4
- 208000008930 Low Back Pain Diseases 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 230000001427 coherent effect Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 230000035622 drinking Effects 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 210000001550 testis Anatomy 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 206010029410 night sweats Diseases 0.000 description 3
- 230000036565 night sweats Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 210000001625 seminal vesicle Anatomy 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 201000010653 vesiculitis Diseases 0.000 description 3
- 206010002660 Anoxia Diseases 0.000 description 2
- 241000976983 Anoxia Species 0.000 description 2
- 206010005963 Bone formation increased Diseases 0.000 description 2
- 206010006100 Bradykinesia Diseases 0.000 description 2
- 241000282994 Cervidae Species 0.000 description 2
- 241001550206 Colla Species 0.000 description 2
- 241000209020 Cornus Species 0.000 description 2
- 208000006083 Hypokinesia Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 231100000111 LD50 Toxicity 0.000 description 2
- 241001307210 Pene Species 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000007953 anoxia Effects 0.000 description 2
- 210000003056 antler Anatomy 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 210000002149 gonad Anatomy 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 210000004706 scrotum Anatomy 0.000 description 2
- 230000036299 sexual function Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000021595 spermatogenesis Effects 0.000 description 2
- 238000010254 subcutaneous injection Methods 0.000 description 2
- 239000007929 subcutaneous injection Substances 0.000 description 2
- 230000004304 visual acuity Effects 0.000 description 2
- 239000005541 ACE inhibitor Substances 0.000 description 1
- 101710129690 Angiotensin-converting enzyme inhibitor Proteins 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 241001330002 Bambuseae Species 0.000 description 1
- UYIFTLBWAOGQBI-BZDYCCQFSA-N Benzhormovarine Chemical compound C([C@@H]1[C@@H](C2=CC=3)CC[C@]4([C@H]1CC[C@@H]4O)C)CC2=CC=3OC(=O)C1=CC=CC=C1 UYIFTLBWAOGQBI-BZDYCCQFSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 101710086378 Bradykinin-potentiating and C-type natriuretic peptides Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N Calcium oxide Chemical compound [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 206010038669 Respiratory arrest Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 239000012891 Ringer solution Substances 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 201000001880 Sexual dysfunction Diseases 0.000 description 1
- BNRNXUUZRGQAQC-UHFFFAOYSA-N Sildenafil Natural products CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 BNRNXUUZRGQAQC-UHFFFAOYSA-N 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000007368 endocrine function Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000001856 erectile effect Effects 0.000 description 1
- 229950002007 estradiol benzoate Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 208000027685 extreme exhaustion Diseases 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000000745 gonadal hormone Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000001662 opsonic effect Effects 0.000 description 1
- 210000004279 orbit Anatomy 0.000 description 1
- 230000021368 organ growth Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 208000012201 sexual and gender identity disease Diseases 0.000 description 1
- 208000015891 sexual disease Diseases 0.000 description 1
- 231100000872 sexual dysfunction Toxicity 0.000 description 1
- DEIYFTQMQPDXOT-UHFFFAOYSA-N sildenafil citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 DEIYFTQMQPDXOT-UHFFFAOYSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 229940094720 viagra Drugs 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | 精子数量(万/10mg附睾组织) | 精子存活率 |
生理盐水组 | 223.5±14.1 | 60.2±4.1% |
实施例1组 | 288.7±21.6 | 88.5±5.2% |
劲酒组 | 235.2±11.3 | 65.6±4.9% |
对比组1 | 238.4±19.5 | 66.3±6.2% |
对比组2 | 243.3±16.7 | 67.6±4.2% |
组别 | 睾丸湿重(mg) | 附睾组织湿重(mg) |
生理盐水组 | 41.3±7.6 | 87.1±12.8 |
实施例1组 | 59.2±12.1 | 121.3±10.9 |
劲酒组 | 48±5.6 | 99±10.7 |
对比组1 | 49.6±8.9 | 99.9±10.8 |
对比组2 | 47.4±5.8 | 98.8±11.1 |
组别 | 平均交尾潜伏期(min) | 平均交尾次数/小时 |
生理盐水组 | 30.4±3.2 | 4.2±0.3 |
实施例1组 | 15.5±2.2 | 9.6±0.4 |
劲酒组 | 23.6±2.8 | 5.1±0.3 |
对比组1 | 26.1±2.6 | 5.2±0.5 |
对比组2 | 25.2±3.4 | 5.0±0.4 |
组别 | 耐缺氧时间(min) |
生理盐水组 | 16.3±1.8 |
实施例1组 | 22.4±1.2 |
劲酒组 | 18.1±1.3 |
对比组1 | 17.9±1.9 |
对比组2 | 17.6±1.5 |
组别 | 游泳时间(min) |
生理盐水组 | 18.3±1.6 |
实施例1组 | 26.2±2.2 |
劲酒组 | 19.2±1.7 |
对比组1 | 19.9±2.4 |
对比组2 | 19.6±1.9 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210224748.0A CN102716315B (zh) | 2012-06-29 | 2012-06-29 | 一种补肾阳保健药酒及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210224748.0A CN102716315B (zh) | 2012-06-29 | 2012-06-29 | 一种补肾阳保健药酒及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102716315A true CN102716315A (zh) | 2012-10-10 |
CN102716315B CN102716315B (zh) | 2014-01-15 |
Family
ID=46942269
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210224748.0A Expired - Fee Related CN102716315B (zh) | 2012-06-29 | 2012-06-29 | 一种补肾阳保健药酒及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102716315B (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104547550A (zh) * | 2015-01-06 | 2015-04-29 | 重庆利莫里亚生物科技有限公司 | 中药组合物及其应用、制备方法、制剂 |
CN104606612A (zh) * | 2015-01-05 | 2015-05-13 | 王元忠 | 一种解酒益肾压片糖果及其制备方法 |
CN104940642A (zh) * | 2015-06-19 | 2015-09-30 | 广西健宝石斛有限责任公司 | 一种具有补肾功能的铁皮石斛保健酒及其制备方法 |
CN105456972A (zh) * | 2014-09-05 | 2016-04-06 | 湖南康寿制药有限公司 | 一种龟鹿益肾中药组合物及其制备方法 |
CN106266241A (zh) * | 2016-09-26 | 2017-01-04 | 周晓浩 | 补肝益肾中药酒 |
CN107236659A (zh) * | 2017-08-13 | 2017-10-10 | 何家平 | 一种黑色保健酒及其制备方法 |
CN107468908A (zh) * | 2017-07-03 | 2017-12-15 | 四川华盛亿科技有限责任公司 | 一种保健药酒及其生产方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1231196A (zh) * | 1998-04-06 | 1999-10-13 | 游文新 | 一种治疗男性性功能减退的胶囊及制作方法 |
US20040105902A1 (en) * | 2002-12-02 | 2004-06-03 | Jiafang Chen | Compositions and methods for treating prostate cancer |
CN1718073A (zh) * | 2005-07-25 | 2006-01-11 | 王浩贵 | 一种甘蓝茶 |
CN1896216A (zh) * | 2006-06-02 | 2007-01-17 | 池在德 | 一种酒及其制备方法 |
-
2012
- 2012-06-29 CN CN201210224748.0A patent/CN102716315B/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1231196A (zh) * | 1998-04-06 | 1999-10-13 | 游文新 | 一种治疗男性性功能减退的胶囊及制作方法 |
US20040105902A1 (en) * | 2002-12-02 | 2004-06-03 | Jiafang Chen | Compositions and methods for treating prostate cancer |
CN1718073A (zh) * | 2005-07-25 | 2006-01-11 | 王浩贵 | 一种甘蓝茶 |
CN1896216A (zh) * | 2006-06-02 | 2007-01-17 | 池在德 | 一种酒及其制备方法 |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105456972A (zh) * | 2014-09-05 | 2016-04-06 | 湖南康寿制药有限公司 | 一种龟鹿益肾中药组合物及其制备方法 |
CN104606612A (zh) * | 2015-01-05 | 2015-05-13 | 王元忠 | 一种解酒益肾压片糖果及其制备方法 |
CN104547550A (zh) * | 2015-01-06 | 2015-04-29 | 重庆利莫里亚生物科技有限公司 | 中药组合物及其应用、制备方法、制剂 |
CN104940642A (zh) * | 2015-06-19 | 2015-09-30 | 广西健宝石斛有限责任公司 | 一种具有补肾功能的铁皮石斛保健酒及其制备方法 |
CN106266241A (zh) * | 2016-09-26 | 2017-01-04 | 周晓浩 | 补肝益肾中药酒 |
CN107468908A (zh) * | 2017-07-03 | 2017-12-15 | 四川华盛亿科技有限责任公司 | 一种保健药酒及其生产方法 |
CN107236659A (zh) * | 2017-08-13 | 2017-10-10 | 何家平 | 一种黑色保健酒及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102716315B (zh) | 2014-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103735838B (zh) | 一种养肾补肾保健药酒及其制备方法 | |
CN101327297B (zh) | 一种治疗失眠的中药组合物 | |
CN102526474B (zh) | 一种治疗神经衰弱的中药组合物 | |
CN102319389A (zh) | 一种治疗消化不良的药物 | |
CN102716315A (zh) | 一种补肾阳保健药酒及其制备方法 | |
CN104586669A (zh) | 一种减肥外用霜 | |
CN104547550A (zh) | 中药组合物及其应用、制备方法、制剂 | |
CN104474417A (zh) | 药食同源中药组合物及其用途、葡萄酒以及葡萄酒的制备方法 | |
CN111588804A (zh) | 一种补元气的药食同源配方 | |
CN101485820B (zh) | 一种中老年保健丸 | |
CN102423407A (zh) | 一种用于调理亚健康状态的中药组合物 | |
CN103494950B (zh) | 一种治疗阳痿的中药胶囊 | |
CN102908396B (zh) | 一种具有促进睡眠作用的中药组合物及其制备方法 | |
CN102335286A (zh) | 一种补肾安神食疗的中药组合物 | |
CN101675983A (zh) | 气虚症温补剂 | |
CN107737319A (zh) | 改善睡眠质量的中药制剂及其制备方法 | |
CN101991829B (zh) | 一种治疗胃病的药物 | |
CN102406784A (zh) | 一种治疗失眠的中药组合物 | |
CN107007775A (zh) | 一种用于痰湿体质的保健中药饮片组合物 | |
CN100548348C (zh) | 一种内服治疗神经衰弱的中药组合物 | |
CN113632979A (zh) | 一种男女通用的四季养生饮料及其制备方法 | |
CN101627823A (zh) | 一种降低人体性功能的咖啡饮品及其制备方法 | |
CN104547642A (zh) | 一种治疗女性纤维肌痛综合征的中药组合物 | |
CN103961578A (zh) | 一种治疗神经衰弱的中药药酒 | |
CN103830649B (zh) | 一种治疗慢性酒精中毒的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: WANG CHENGYUAN Free format text: FORMER OWNER: CHONGQING TECHNOLOGY AND BUSINESS UNIVERSITY Effective date: 20141225 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 400067 NANAN, CHONGQING TO: 400060 NANAN, CHONGQING |
|
TR01 | Transfer of patent right |
Effective date of registration: 20141225 Address after: 400060 University Avenue Nanping Nan'an District of Chongqing City No. 22 Xuefu garden 2-21-6 Patentee after: Wang Chengyuan Address before: Industrial and Commercial University Of Chongqing special No. 19 University Avenue 400067 Nanping Nan'an District of Chongqing city 81102 Patentee before: Chongqing Technology and Business University |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140115 |